BusinessSummit Presents New 24-Week Analyses from PhaseOut DMD at the 2018 American Academy of Neurology Annual MeetingBy Nasdaq OMXApr 20, 2018, 11:00 AM UTC
BusinessSummit Completes Dosing of Ezutromid in PhaseOut DMD Clinical TrialBy Nasdaq OMXApr 19, 2018, 11:01 AM UTC
BusinessSummit Announces New Analysis Showing Ezutromid Significantly Reduced Muscle Inflammation in Phase 2 Clinical Trial in DMDBy Nasdaq OMXFeb 26, 2018, 12:00 PM UTC
BusinessEzutromid Significantly Reduced Muscle Damage in DMD Patients in 24-Week Interim Data From Summit’s PhaseOut DMD Clinical TrialBy Nasdaq OMXJan 25, 2018, 12:01 PM UTC
BusinessEarth Science Tech, Inc. Signs Agreement with TransBiotech to start in Vitro & in Vivo in Phase II for Nutraceutical PatentsBy Nasdaq OMXNov 14, 2017, 1:01 PM UTC
BusinessWOWIO, INC. Acquires Land to be developed into low cost housing in Northern CaliforniaBy Nasdaq OMXNov 9, 2017, 11:30 AM UTC
BusinessSummit Highlights Microbiome Preservation During Ridinilazole Treatment in Exploratory Phase 2 Clinical Trial at ID Week 2017By Nasdaq OMXOct 9, 2017, 11:00 AM UTC
BusinessEarth Science Tech Inc. Signs Contract with CDBQ to Advance Phase-2 Rollout on it’s CBD PatentsBy Nasdaq OMXAug 1, 2017, 12:25 PM UTC
